NASDAQ:LMRI

LMRI shares up after insider buy; Wall Street cut trims gains
····

LMRI shares up after insider buy; Wall Street cut trims gains

Lumexa Imaging closed at $8.18 Thursday, up 10.5%, and traded at $8.53 after hours following news that director Brett Brodnax bought 35,000 shares at $7.25 each. Barclays cut its price target to $9 from $15, citing stronger growth at rival RadNet. Lumexa’s shares remain below their $18.50 IPO price from December. The company reaffirmed its 2026 revenue and earnings outlook.
May 22, 2026

Stock Market Today

  • Dividend Shares in ASX 200 Attract Investor Interest
    May 28, 2026, 9:32 PM EDT. Dividend-paying shares across the ASX 200 are drawing significant market attention. Investors are focusing on companies offering stable or growing dividends as economic uncertainties persist. Dividend yields have become a key consideration for portfolio strategies, especially amid low interest rates. ASX 200 constituents with attractive payouts are benefiting from increased demand, highlighting the role of dividends in investor decision-making. Market watchers note dividends can provide income and signal company strength, influencing stock performance and investor sentiment.